Trials / Completed
CompletedNCT01015859
Spontaneous Atrioventricular Conduction Preservation
A Prospective Canadian Multi-center Randomized Study of the Benefits of Spontaneous Atrioventricular Conduction (Can Save R)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 370 (actual)
- Sponsor
- Montreal Heart Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aims of this study are to assess the clinical benefits resulting from SafeR by comparison with standard dual chamber programming (DDD) with a long atrioventricular (AV) delay. The benefits will be assessed by comparing the percentage of ventricular pacing, the incidence of atrial arrhythmias, and the evolution of the hemodynamic status as observed through echo parameter and atrial natriuretic peptide/brain natriuretic peptide (ANP/BNP) measurements.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pacing mode | To determine which mode (DDD vs AAI SafeR)minimizes ventricular pacing |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2012-08-01
- Completion
- 2013-10-01
- First posted
- 2009-11-18
- Last updated
- 2013-10-30
Locations
9 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01015859. Inclusion in this directory is not an endorsement.